Sorrel believes in making people healthier their way.
By innovating and manufacturing wearable drug delivery devices that deliver more, Sorrel optimizes both patient experience and pharma companies’ value.
We partner to provide our powerhouse capabilities in technological flexibility, regulatory compliance, manufacturing scale-up, and marketing expertise, for a true platform solution. Spun out of the established Israeli-based medical device leader Q Core Medical, and under the leadership of the Eitan Group, Sorrel leverages the group’s massive operational wingspan and its proven experience to provide advanced wearable drug delivery devices. Our approach at Sorrel is all about applying technology that simplifies processes for end-users and companies. We are committed to continuously paving the way forward with innovative technology solutions to previously unaddressed needs of the drug delivery market.
Eitan Group is reinventing drug delivery across the continuum of care with connected, software-based solutions from the hospital to the home. Building new levels of interconnectivity for infusion systems, and integrating innovation with wearables drug delivery platforms, the Company is creating user-friendly, patient-centric solutions to meet evolving drug delivery needs.
Leading expert in drug delivery device technology and high-end development processes, Andrei applies his industry insight to steer forward Sorrel’s multidisciplinary team. He served in several executive positions at Q Core for a decade, before taking the helm at Sorrel. Andrei holds a PhD in Biomedical Engineering and an MA in Mechanical Engineering, both from the Technion – Israel Institute of technology.
Yuval brings with him over two decades of finance management, to oversee the financial strategy and operations at Sorrel. Prior to this position, he was CFO at Eitan, Mehulal & Sadot Advocates and Patent Attorneys, and a senior accountant at Yungerman-Gilboa-Zilber CPAs. Yuval is a certified public accountant, with a BA in Accounting and Business Administration from the College of Management Academic Studies.
Leveraging 15 years of commercial development experience in the wearable injector drug delivery industry and over 25 years of experience in managing global business development, sales and marketing strategies, Michael Ratigan acts as the Chief Commercial Officer of Sorrel Medical. Michael Ratigan is a global leader in contract development and manufacturing services for the medical / drug delivery markets. He served as the vice president of global sales and marketing at Molex company, Phillips-Medisize. Michael acted as the senior vice president and CCO at Unilife Corporation, a provider of injectable drug delivery systems. Additionally, he served as a worldwide business platform leader at Becton Dickinson (BD).
Director of Production
With a comprehensive command of connected medical devices and software development, Arik heads the implementation of Sorrel’s innovative technology vision. For over 30 years, he served in various leadership positions as R&D and product manager, including CTO at Q Core and Director of Product Management at Gilat Satellite Networks. He is the co-founder of Nice Systems and NiceCom, acquired by 3Com. Arik holds an MA in Entrepreneurship and Innovation from Swinburne University, and a BSc in Mathematics and Computer Science from Tel-Aviv University.
PhD, Director of R&D
Ori heads Sorrel’s research and development programs, applying his extensive hands-on expertise in medical device innovation. Prior to joining the Sorrel executive team, Ori served as Manager of Research and Mechanics at Q Core Medical, and R&D Director at Bmax. He holds a PhD in Energy, and an MSc and BSc in Mechanical Engineering, all from Ben-Gurion University of the Negev.
Director of Product
Leading the marketing, product management and business development activities at Sorrel, Mindy applies her business acumen, industry insight, and thought leadership to define features and functions of Sorrel's products, while overseeing business relations with Sorrel's partners. She previously served as Program Manager at Q Core Medical, where she worked across multidisciplinary teams, building structured and collaborative partnerships between companies in the world of drug delivery. Mindy holds a BSc in Biomedical Engineering from the Technion – Israel Institute of Technology.
PhD, Chairman of the Board
Passionate about technological innovation and the owner of more than 80 registered patents, Boaz serves as Chairman of the Board at Sorrel. He is deeply involved in the company’s ongoing operations, sharing his visionary insight to propel product innovation and growth. Boaz also heads Q Core Medical as CEO, owner, and Chairman. Prior to his acquisition of Q Core Medical, he held several executive positions in the semiconductor industry, including an 11-year tenure in Silicon Valley. He founded Saifun Semiconductors based on his proprietary invention NROM memory technology, leading the company’s IPO on NASDAQ followed by a merger with Spansion Semiconductors. Today, products applying this technology account for over $2B in annual sales. Boaz holds a PhD and MSc in Applied Physics, and a BSc in Physics and Mathematics- all from The Hebrew University of Jerusalem.
Chairman of the Eitan Group
The life force behind Sorrel’s business strategy and regulatory approach, Tally is highly experienced in counseling innovation companies in complex aspects of technology, law, and business. She is the Chairman of the Eitan Group, President of Q Core Medical, and a technology transaction lawyer with vast involvement in California and Israel, founder of the leading Israeli commercial law firm Eitan, Mehulal & Sadot Advocates and Patent Attorneys. Tally is renowned as one of Israel’s most prominent intellectual property lawyers, and holds a BS in Statistics and a JD, both from The Hebrew University of Jerusalem.
A renowned opinion leader in the world of drug delivery devices, Kevin has joined the Sorrel Board of Directors to provide guidance on operations, market challenges, and next-frontier technologies. Previously he held positions with the Stevanato Group as Vice President of Drug Delivery Systems, and with Insulet Corporation as Vice President of Business Development and Advanced Technology, Vice President of Manufacturing and Vice President of Operations and Engineering. Kevin currently serves as COO at Common Sensing, and holds an MBA from Sacred Heart University, and BSc in Mechanical Engineering from Clarkson University.
Shaul has gained a unique interdisciplinary background in technology, finance, and marketing, a diversified skill set that he shares to guide Sorrel as a board member. His knowledge also expands into smart medical devices, infusion market landscape, and business strategy leadership. Shaul currently serves as CEO of Avoset Health, and in the past served as COO at Q Core Medical, where he led the Marketing and Operations activities. Shaul holds a BSc in Electrical Engineering from Tel Aviv University.
Driven by her extensive knowhow in patents and technological innovation, Anat’s guidance is imperative for the Sorrel IP portfolio. She is an accomplished electrical engineer, also experienced in VLSI circuit design and in-house patent administration. Anat is a registered US Patent Agent, holding an MA in Patent Law from Haifa University, and a BSc in Electrical Engineering from Ben Gurion University of the Negev.
A key leader in the semiconductor capital equipment industry for over three decades, Ken serves on the Board of Directors at Sorrel, where he offers his vast business perspective and profound understanding of the global technological arena. Ken has held several key positions in diverse fields, and is a Director Emeritus on the Board of Semiconductor Equipment and Materials Institute (SEMI). Ken is also the founder of KLA Instruments Corporation. He holds a MSc in Electrical Engineering from Syracuse University and a BSc in Electrical Engineering from City College of New York.
Igal’s business acumen is indispensable for the Sorrel team, and he has joined the company’s Board of Directors to drive company growth. Igal serves as CFO at Kenshoo, is the Managing Director at Aulder Capital (formerly BZ Investment LLC), and is a Member of the Board at Q Core Medical and Kando Clear Upstream. He holds an MBA in Finance and a BA in Accounting and Economics, both from Tel Aviv University.